Abstract
Development of animal models is a crucial issue in biological psychiatry. Animal models provide the opportunity to decipher the relationships between the nervous system and behavior and they are an obligatory step for drug tests. Mouse models or rat models to a lesser extent could help to test for the implication of a gene using gene targeting or transfecting technologies. One of the main problem for the development of animal models is to define a marker of the psychiatric disorder. Several markers have been suggested for schizophrenia and autism, but for the moment no markers or etiopathogenic mechanisms have been identified for these disorders. We examined here animal models related to schizophrenia and autism and discussed their validity and limitations after first defining these two disorders and considering their similarities and differences. Animal models reviewed in this article test mainly behavioral dimensions or biological mechanisms related to autistic disorder or schizophrenia rather than providing specific categorical models of autism or schizophrenia. Furthermore, most of these studies focus on a behavioral dimension associated with an underlying biological mechanism, which does not correspond to the complexity of mental disorders. It could be useful to develop animal models relevant to schizophrenia or autism to test a behavioral profile associated with a biological profile. A multi-trait approach seems necessary to better understand multidimensional disorders such as schizophrenia and autism and their biological and clinical heterogeneity. Finally, animal models can help us to clarify complex mechanisms and to study relationships between biological and behavioral variables and their interactions with environmental factors. The main interest of animal models is to generate new pertinent hypotheses relevant to humans opening the path to innovative research.
Similar content being viewed by others
References
Abraini JH, Ansseau M, Fechtali T (1993) Pressure-induced disorders in neurotransmission and spontaneous behavior in rats: an animal model of psychosis. Biol Psychiatry 34:622–629
Alaghband-Rad J, McKenna K, Gordon CT (1995) Childhood onset schizophrenia: the severity of premorbid course. J Am Acad Child Adolesc Psychiatry 34:1275–1283
American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders (4th edn. Text revision). American Psychiatric Association, Washington, DC
Andres C (2002) Molecular genetics and animal models in autistic disorder. Brain Res Bull 57(1):109–119
Asarnow JR, Tompson MC, Goldstein MJ (1994) Childhood-onset schizophrenia: a followup study. Schizophr Bull 20(4):599–617
Bachevalier J (1996) Brief report: medial temporal lobe and autism: a putative animal model in primates. J Autism Dev Disord 26(2):217–220
Bailer J, Brauer W, Rey ER (1996) Premorbid adjustment as predictor of outcome in schizophrenia results of a prospective study. Acta Psychiatr Scand 93(5):368–377
Bailey A, Luthert P, Dean A (1998) A clinicopathological study of autism. Brain 121:889–905
Baum KM, Walker EF (1995) Childhood behavioral precursors of adult symptom dimensions in schizophrenia. Schizophr Res 16:111–120
Bauman ML, Kemper TL (1985) Histoanatomic observations in the brain in early infantile autism. Neurology 35:866–874
Bauman ML, Le May M, Bauman RA, Rosenberger PB (1985) Computerized tomographic (CT) observations of the posterior fossa in early infantile autism (abstract). Neurology 35(1 Suppl):247S
Baxter LL, Moran TH, Richtsmeier JT, Troncoso J, Reeves RH (2000) Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse. Hum Mol Genet 9:195–202
Bender L, Faetra G (1972) The relationship between childhood and adult schizophrenia. In: Kaplan AR (ed) Genetic factors in schizophrenia. Charles C. Thomas Publisher, Springfield III, pp 28–64
Berger P, Watson S, Akil H, Barchas JD (1981) Clinical studies on the role of endorphins in schizophrenia. Mod Probl Pharmacopsychiatr 17:226–235
Bleuler E (1911) Dementia Praecox oder Gruppe der Schizophrenien. Handbuch der Psychiatrie, Leipzig, Aschaffenburg
Braff DL, Geyer MA (1990) Sensorimotor gating and schizophrenia. Human and animal model studies. Arch Gen Psychiatry 47:181–188
Braff D, Stone C, Callaway E, Geyer M, Glick I, Bali L (1978). Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15:339–343
Brambilla F, Facchinetti F, Petraglia F, Vanzulli L, Genazzani AR (1984) Secretion pattern of endogenous opioids in chronic schizophrenia. Am J Psychiatry 141:1183–1188
Campbell M, Anderson LT, Small AM, Locascio JJ, Lynch NS, Choroco MC (1990) Naltrexone in autistic children: a double-blind and placebo-controlled study. Psychopharmacol Bull 26:130–135
Cantor S, Evans J, Pearce J, Pezzot-Pearce T (1982) Childhood schizophrenia: present but not accounted for. Am J Psychiatry 139:758–762
Carpenter WT, Heinrichs DW, Wagman AM (1988) Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry 145:578–583
Caston J, Yon E, Mellier D, Godfrey HP, Delhaye-Bouchaud N, Mariani J (1998) An animal model of autism: behavioural studies in the GS guinea-pig. Eur J Neurosci 10(8):2677–2684
Chamberlain RS, Herman BH (1990) A novel biochemical model linking dysfunctions in brain melatonin, proopiomelanocortin peptides, and serotonin in autism. Biol Psychiatry 28:773–793
Chisaka O, Musci TS, Capecchi MR (1992) Developmental defects of the ear, cranial nerves and hindbrain resulting from targeted disruption of the mouse homeobox gene Hox 1.6. Nature 355:516–520
Christison GW, Atwater GE, Dunn LA, Kilts CD (1988) Haloperidol enhancement of latent inhibition: relation to therapeutic action? Biol Psychiatry 23:746–749
Chua SE, Murray RM (1996) The neurodevelopmental theory of schizophrenia: evidence concerning structure and neuropsychology. Ann Med 28:547–555
Collins JS, Schroer RJ, Bird J, Michaelis RC (2003) The HOXA1 A218G polymorphism and autism: lack of association in white and black patients from the South Carolina Autism Project. J Autism Dev Disord 33:343–348
Conciatori M, Stodgell CJ, Hyman SL, O’bara M, Militerni R, Bravaccio C, Trillo S, Montecchi F, Schneider C, Melmed R, Elia M, Crawford L, Spence SJ, Muscarella L, Guarnieri V, D’agruma L, Quattrone A, Zelante L, Rabinowitz D, Pascucci T, Puglisi-Allegra S, Reichelt KL, Rodier PM, Persico AM (2004) Association between the HOXA1 A218G polymorphism and increased head circumference in patients with autism. Biol Psychiatry 55:413–419
Courchesne E, Saitoh O, Yeung CR, Press GA, Lincoln AJ, Haas RH, Schreibman L (1994) Abnormalities of cerebellar vermian lobules VI and VII in patients with infantile autism: identification of hypoplastic and hyperplastic subgroups with MR imaging. AJR Am J Roentgenol 162:123–130
Courchesne E, Yeung-Courchesne R, Press GA, Hesslink JR, Jernigan TL (1987) Hypoplasia of cerebellar vermal lobules VI & VII in autism. N Engl J Med 318:1349–1354
Crawley JN (2004) Designing mouse behavioral tasks relevant to autistic-like behaviors. MRDD Res Rev 10:248–258
Devlin B, Bennett P, Cook EH, Dawson G, Gonen D, Grigorenko EL, Mcmahon W, Pauls D, Smith M, Spence MA, Schellenberg GD (2002) No evidence for linkage of liability to autism to HOXA1 in a sample from the CPEA network. Am J Med Genet 114:667–672
Dihoff RE, Hetznecker W, Brosvic GM, Carpenter LN, et al (1993) Ordinal measurement of autistic behavior: a preliminary report. Bull Psychonom Soc 31:287–290
Dunn LA, Atwater GE, Kilts CD (1993) Effects of antipsychotic drugs on latent inhibition: sensitivity and specificity of an animal behavioral model of clinical drug action. Psychopharmacology (Berl) 112:315–323
Ellenbroek BA, Artz MT, Cools AR (1991) The involvement of dopamine D1 and D2 receptors in the effects of the classical neuroleptic haloperidol and the atypical neuroleptic clozapine. Eur J Pharmacol 196:103–108
Ellenbroek BA, Geyer MA, Cools AR (1995) The behavior of APO-SUS rats in animal models with construct validity for schizophrenia. J Neurosci 15:7604–7611
Ellenbroek BA, Willemen AP, Cools AR (1989) Are antagonists of dopamine D1 receptors drugs that attenuate both positive and negative symptoms of schizophrenia? A pilot study in Java monkeys. Neuropsychopharmacology 2:191–199
Engelmann M, Landgraf R (1994) Microdialysis administration of vaso-pressin into the septum improves social recognition in Brattleboro rats. Physiol Behav 55:145–149
Feldon J, Weiner I (1991) The latent inhibition model of schizophrenic attention disorder. Haloperidol and sulpiride enhance rats’ ability to ignore irrelevant stimuli. Biol Psychiatry 29:635–646
Ferguson JN, Aldag JM, Insel TR, Young LJ (2001) Oxytocin in the medial amygdala is essential for social recognition in the mouse. J Neurosci 21:8278–8285
Ferguson JN, Young LJ, Hearn EF, Matzuk MM, Insel TR, Winslow JT (2000) Social amnesia in mice lacking the oxytocin gene. Nat Genet 25:284–287
Filipek PA, Richelme C, Kennedy DN, Rademacher J, Pitcher DA, Zidel SY, Caviness VS (1992) Morphometric analysis of the brain in developmental language disorders and autism. Ann Neurol 32:475
Fisch GS (2005) Invited comment. Syndromes and epistemology I: autistic spectrum disorders. Am J Med. Genet 135A:117–119
Fone KC, Nutt DJ (2005) Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder. Curr Opin Pharmacol 1:87–93
Freedman R, Waldo M, Bickford-Wimer P, Nagamoto H (1991) Elementary neuronal dysfunctions in schizophrenia. Schizophr Res 4:233–243
Frescka E, Davis KL (1991) The opioid model in psychiatric research. In: Nemeroff CB (ed) Neuropeptides and psychiatric disorders. American Psychiatric Press, Washington, DC, pp 169–191
Friedlander K (1946). Psychoanalytic orientation in child guidance work in Great Britain. Psychoanal Study Child 2:343–357
Gaffney GR, Kuperman S, Tsai LT, Minchin S, Hassanein KM (1987) Mid-sagittal magnetic resonance imaging of autism. Br J Psychiatry 151:831–833
Gallagher L, Hawi Z, Kearney G, Fitzgerald M, Gill M (2004) No association between allelic variants of HOXA1/HOXB1 and autism. Am J Med Genet 124B:64–67
Garber HJ, Ritvo E, Chui LC, Griswold VJ, Kashanian A, Oldendorf WH (1989) A magnetic resonance imaging study of autism: normal fourth ventricle size and absence of pathology. Am J Psychiatry 146:532–534
Geyer MA, Markou A (2002) Animal models of psychiatric disorders. In: Davis KL, Charney D, Coyle JT, Nemeroff C (eds) Neuropsychopharmacology: the fifth generation of progress. Lippincott Williams & Wilkins, New York, pp 445–455
Gray JA (1998) Integrating schizophrenia. Schizophr Bull 24:249–266
Green L, Fein D, Modahl C, Feinstein C, Waterhouse L, Morris M (2001) Oxytocin and autistic disorder: alterations in peptide forms. Biol Psychiatry 50:609–613
Guieu R, Samuelian JC, Coulouvrat H (1994) Objective evaluation of pain perception in patients with schizophrenia. Br J Psychiatry 164:253–255
Guimera J, Casas C, Pucharcos C, Solans A, Domenech A, Planas M, Asley J, Lovett M, Estivill X, Pritchard MA (1996) A human homologue of Drosophila minibrain (MBN) is expressed in the neuronal regions affected in Down syndrome and maps to the critical region. Hum Mol Genet 9:1305–1310
Harlow HF, McKinney WT (1971) Non-human primates and psychoses. J Autism Child Schiz 1:368–375
Herman BH, Panksepp J (1978) Effects of morphine and naloxone on separation distress and approach attachment: evidence for opiate medication of social affect. Pharmacol Biochem Behav 9:213–220
Holtum JR, Minshew NJ, Sanders RS, Phillips NE (1992) Magnetic resonance imaging of the posterior fossa in autism. Biol Psychiatry 32:1091–1101
Hooper M, Hardy K, Handyside A, Hunter S, Monk M (1987) HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature 326:295–298
Houpt KA, McDonell SM (1993) Equine stereotypies. Comp Contin Educ Pract Vet 15:1265–1272
Ingram JL, Peckham SM, Tisdale B, Rodier PM (2000a) Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol Teratol 22:319–324
Ingram JL, Stodgell CJ, Hyman SL, Figlewicz DA, Weitkamp LR, Rodier PM (2000b) Discovery of allelic variants of HOXA1 and HOXB1: genetic susceptibility to autism spectrum disorders. Teratology 62:393–405
Insel TR, O’Brien DJ, Leckman JF (1999) Oxytocin, vasopressin, and autism: is there a connection? Biol Psychiatry 45:145–157
Ito M (1998) Cerebellar learning in vestibulo-ocular reflex. Trends Cognit Sci 2:313–321
Jacobson JW, Ackerman LJ (1990) Differences in adaptive functioning among people with autism or mental retardation. J Autism Dev Disord 20:205–219
Jansen LMC (1998) Blunted cortisol response to a psychosocial stressor in schizophrenia. Schizophr Res 33:87–94
Jansen LMC, Gispen-De Wied CC, Van Der Gaag RJ, Ten Hove F, Willemsenswinkels SWM, Harteveld E, Van Engeland H (2000) Unresponsiveness to psychosocial stress in a subgroup of autistic-like children, multiple complex developmental disorder. Psychoneuroendocrinology 25:753–764
Kahne D, Tudorica A, Borella A, Shapiro L, Johnstone F, Huang W, Whitaker-Azmitia PM (2002) Behavioral and magnetic resonance spectroscopic studies in the rat hyperserotonemic model of autism. Physiol Behav 75:403–410
Kalat JM (1978). Speculations or similarities between autism and opiate addiction. J Autism Child Schizophr 8:477–479
Kanner L (1943) Austistic disturbances of affective contact. Nervous Child 32:217–253
Kilts CD (2001) The changing roles and targets for animal models of schizophrenia. Biol Psychiatry 50:845–855
Kleiman MD, Neff S, Rosman NP (1992) The brain in infantile autism: are posterior fossa structures abnormal? Neurology 42:753–760
Kline NS, Li CH, Lehmann HE, Lajtha A, Laski E, Cooper T (1977) Beta-endorphin-induced changes in schizophrenic and depressed patients. Arch Gen Psychiatry 34:1111–1113
Konstantareas MM, Hewitt T (2001) Autistic disorder and schizophrenia: diagnostic overlaps. J Autism Dev Disord 31(1):19–28
Krause I, He XS, Gershwin ME, Shoenfeld Y (2002) Brief report: immune factors in autism: a critical review. J Autism Dev Disord 32:337–345
Krauss H, Marwinski K, Schulze T, Mueller DJ, Held T, Rietschel M, Maier W, Freyberger HJ (2000) Reliability and validity of the German version of the Premorbid Adjustment Scale (PAS). Nervenarzt 71(3):188–194
Kuehn MR, Bradley A, Robertson EJ, Evans MJ (1987) A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice. Nature 326:295–298
Larsen TK, Mouridsen SE (1997) The outcome in children with childhood autism and Asperger syndrome originally diagnosed as psychotic. A 30-year follow-up study of subjects assessed as children. Eur Child Adol Psychiatr 6:181–190
Lev-Ram V, Valsamis M, Masliah E, Levine S, Godfrey HP (1993) A novel non-ataxic guinea pigstrain with cerebrocortical and cerebellar abnormalities. Brain Res 606:325–331
Li J, Tabor HK, Nguyen L, Gleason C, Lotspeich LJ, Spiker D, Risch N, Myers RM (2002) Lack of association between HOXA1 and HOXB1 gene variants and autism in 110 multiplex families. Am J Med Genet 114:24–30
Lijam N, Paylor R, McDonald MP, Crawley JN, Deng CX, Herrup K, Stevens KE, Maccaferri G, McBain CJ, Sussman DJ, Wynshaw-Boris A (1997) Social interaction and sensorimotor gating abormalities in mice lacking Dvl1. Cell 90:895–905
Lindstrom LH, Besev G, Gunne LM, Terenius L (1986) CSF levels of receptor-active endorphins in schizophrenic patients: correlations with symptomatology and monoamine metabolites. Psychiatry Res 19:93–100
Lipska BK, Halim ND, Segal PN, Weinberg DR (2002) Effects of reversible inactivation of the neonatal ventral hippocampus on behavior in the adult rat. J Neurosci 22:2835–2842
Lipska BK, Weinberger DR (2000) To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology 23:223–239
Lipska BK, Weinberger DR (2002) A neurodevelopmental model of schizophrenia: neonatal disconnection of the hippocampus. Neurotox Res 4:469–475
Lubow RE (1973) Latent inhibition. Psychol Bull 79:398–407
Malhotra AK, Goldman D, Mazzanti C, Clifton A, Breier A, Pickard D (1998) A functional serotonin transporter (5-HTT) polymorphism is associated with psychosis in neuroleptic-free schizophrenics. Mol Psychiatry 3:328–332
Marcotte ER, Pearson DM, Srivastava LK (2001) Animal models of schizophrenia: a critical review. J Psychiatry Neurosci 26(5):395–410
McKinney WT (1977) Biobehavioral models of depression in monkeys. In: Usdin E, Hanin I (eds) Animal models in psychiatry and neurology. Pergamon Press, Oxford, pp 117–126
Modahl C, Green L, Fein D, Morris M, Waterhouse L, Feinstein C, Levin H (1998) Plasma oxytocin levels in autistic children. Biol Psychiatry 43:270–277
Moser PC, Hitchcock JM, Lister S, Moran PM (2000) The pharmacology of latent inhibition as an animal model of schizophrenia. Brain Res Rev 33:275–307
Mueser KT, Bellack AS, Douglas MS, Morrison RL (1991) Prevalence and stability of social skill deficits in schizophrenia. Schizophr Res 5:167–176
Murcia CL, Gulden F, Herrup K (2005) A question of balance: a proposal for new mouse models of autism. Int J Devl Neuroscience 23:265–275
Nielsen EB, Lyon M, Ellison G (1983) Apparent hallucinations in monkeys during around-the-clock amphetamine for seven to fourteen days. Possible relevance to amphetamine psychosis. J Nerv Ment Dis 171:222–233
Panksepp J (1979) A neurochemical theory of autism. Trends Neurosci 2:174–177
Panksepp J, Herman BH, Vilberg T, Bishop P, DeEskinazi FG (1980a) Endogenous opioids and social behavior. Neurol Biobehav Rev 4:473–487
Panksepp J, Meeker R, Bean NJ (1980b) The neurochemical control of crying. Pharmacol Biochem Behav 12:437–443
Panksepp J, Sahley TL (1987) Possible brain opioid involvement in disrupted social intent and language development of autism. In: Schopler E, Mesibov GB (eds) Neurobiological issues in autism. Plenum Press, New York, pp 357–372
Panksepp J, Siviy SM, Normansell LA (1985) Brain opioids and social emotions. In: Reite M, Field T (eds) The psychobiology of attachment and separation. Academic Press, New York, pp 3–49
Panksepp J, Vilberg T, Bean NJ, Coy DH, Kastin AJ (1978) Reduction of distress vocalization in chicks by opiate-like peptides. Brain Res Bull 3:663–667
Peters SL, Gray JA, Joseph MH (1991) Pre-weaning non-handling of rats disrupts latent inhibition in males, and results in persisting sex- and area-dependent increases in dopamine and serotonin turnover. Behav Pharmaco 12:215–223
Piven J, Nehme E, Simon J, Barta P, Pearlson G, Folstein S (1992) Magnetic resonance imaging in autism: measurement of the cerebellum, pons, and fourth ventricle. Biol Psychiatry 31:491–504
Pletnikov MV, Rubin SA, Moran TH, Carbone KM (2003) Exploring the cerebellum with a new tool: neonatal Borna disease virus (BDV) infection of the rat’s brain. Cerebellum 2(1):62–70
Pletnikov MV, Rubin SA, Vasudevan K, Moran TH, Carbone KM (1999) Developmental brain injury associated with abnormal play behavior in neonatally Borna disease virus-infected Lewis rats: a model of autism. Behav Brain Res 100:43–50
Poznanski EO (1976) Children’s reactions to pain: a psychiatrist’s perspective. Clin Pediatr 15:1114–1119
Rand MS (2004) Selection of animal models. Research animal methods. University of Arizona, Tucson
Ritvo ER, Freeman BJ, Scheibel AB, Duong T, Robinson H, Guthrie D, Ritvo A (1986) Lower purkinje cell counts in the cerebellum of four autistic subjects: initial findings of the UCLA-NSAC Autopsy Research Report. Am J Psychiatry 143:862–866
Robbins TW, Sahakian BJ (1979) “Paradoxical” effects of psychomotor stimulant drugs in hyperactive children from the standpoint of behavioural pharmacology. Neuropharmacology 18:931–950
Robins LN, Helzer JE (1986) Diagnostic and clinical assessment: the current state of psychiatric diagnosis. Ann Rev Psychol 37:409–432
Rodier PM, Ingram JL, Tisdale B, Croog VJ (1997) Linking etiologies in humans and animal models: studies of autism. Reprod Toxicol 11:417–422
Romano V, Cali F, Mirisola M, Gambino GRDA, Di Rosa P, Seidita G, Chiavetta V, Aiello F, Canziani F, De Leo G, Ayala GF, Elia M (2003) Lack of association of HOXA1 and HOXB1 mutations and autism in Sicilian (Italian) patients. Mol Psychiatry 8:716–717
Roubertoux PL, Guillot PV, Mortaud S, Pratte M, Jamon M, Cohen-Salmon C, Tordjman S (2005) Attack behaviors in mice: from factorial structure to quantitative trait loci mapping. Eur J Pharmacol 526(1–3):172–85
Roubertoux PL, Kerdelhué B (2006) Trisomy 21: from chromosomes to mental retardation. Behav Genet 36:344–468
Sahley TL, Panksepp J (1987) Brain opioids and autism: an updated analysis of possible linkages. J Autism Dev Disord 17:201–216
Salamone JD, Cousins MS, Snyder BJ (1997) Behavioral functions of nucleus accumbens dopamine: empirical and conceptual problems with the anhedonia hypothesis. Neurosci Biobehav Rev 21:341–359
Sandman CA (1992) Various endogenous opioids and autistic behavior: a response to Gillberg (letter to the editor). J Autism Dev Disord 22:132–133
Sandman CA, Barron JL, Chicz-Demet A, Demet EM (1991) Brief report: plasma β-endorphin and cortisol levels in autistic patients. J Autism Dev Disord 21:83–87
Sandman CA, McGivern RF, Berka C, Walker JM, Coy DH, Kastin AJ (1979) Neonatal administration of beta-endorphin produces «chronic» insensitivity to thermal stimuli. Life Sci 25:1755–1760
Schaefer GB, Thompson JN, Bodensteiner JB, McConnell JM, Kimberling WJ, Gay CT, Dutton WD, Hutchings DC, Gray SB (1996) Hypoplasia of the cerebellar vermis in neurogenetic syndromes. Ann Neurol 39:382–384
Schmajuk NA (1987). Animal models for schizophrenia: the hippocampally lesioned animal. Schizophr Bull 13:317–327
Shalev U, Feldon J, Weiner I (1998) Gender- and age-dependent differences in latent inhibition following pre-weaning non-handling: implications for a neurodevelopmental animal model of schizophrenia. Int J Dev Neurosci 16:279–288
Shalev U, Weiner I (2001) Gender-dependent differences in latent inhibition following prenatal stress and corticosterone administration. Behav Brain Res 126:57–63
Sher L (1997) Autistic disorder and the endogenous opioid system. Med Hypotheses 48:413–414
Singh MK, Giles LL, Nasrallah HA (2006) Pain insensitivity in schizophrenia: trait or state marker? J Psychiatr Pract 12(2):90–102
Solomon PR, Cride RA, Winkelman JW, Turi A, Kamer RM, Kaplan LJ (1981) Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: relationship to schizophrenic attention disorder. Biol Psychiatry 16:519–537
Soubrié P, Simon P (1989) Les modèles animaux en psychopharmacologie. Confrontations Psy: Les modèles expérimentaux et la clinique psychiatrique 30:113–129
Strömland K, Nordin V, Miller MT, Akerstrom B, Gillberg C (1994) Autism in thalidomide embryopathy: a population study. Dev Med Child Neurol 36:351–356
Swerdlow NR, Braff DL, Geyer MA, Koob GF (1986) Central dopamine hyperactivity in rats mimics abnormal acoustic startle response in schizophrenics. Biol Psychiatry 21:23–33
Swerdlow NR, Braff DL, Masten VL, Geyer MA (1990) Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens. Psychopharmacology 101:414–420
Swerdlow NR, Keith VA, Braff DL, Geyer MA (1991) Effects of spiperone, raclopride, SCH 23390 and clozapine on apomorphine inhibition of sensorimotor gating of the startle response in the rat. J Pharmacol Exp Ther 256:530–536
Szatmari P, Merette C, Bryson SE, Thivierge J, Roy MA, Cayer M, Maziade M (2002) Quantifying dimensions in autism: a factor-analytic study. J Am Acad Child Adolesc Psychiatry 4:467–474
Talebizadeh Z, Bittel DC, Miles JH, Takahashi N, Wang CH, Kibiryeva N, Butler MG (2002) No association between HOXA1 and HOXB1 genes and autism spectrum disorders (ASD). J Med Genet 39:70
Tantam D (1988) Asperger’s syndrome. J Child Psychol Psychiatry 29:245–255
Tanguay PE (2000) Pervasive developmental disorders: a 10-year review. J Am Acad Child Adolesc Psychiatry 39:1079–1095
Thach WT (1998) What is the role of the cerebellum in motor learning and cognition? Trends Cognit Sci 2:331–337
Tordjman S, Anderson G, Macbride A, Hetzig M, Snow M, Hall L, Ferrari P, Cohen DJ (1997) Plasma B. endorphin, adrenocorticotropin hormone and cortisol in autism. J Child Psychol Psychiatry 38(6):705–716
Tordjman S, Antoine C, Cohen DJ, Gauvain-Piquard A, Carlier M, Roubertoux PL, Ferrari P. (1999). Etude des conduites autoagressives, de la réactivité à la douleur et de leurs interrelations chez les enfants autistes. L’Encéphale 25:122–134
Tordjman S, Carlier M, Cohen D, Cesselin F, Bourgoin S, Colas-Linhart N, Petiet A, Perez-Diaz F, Hamon M, Roubertoux PL (2003) Aggression and the three opioid families (Endorphins, Enkephalins and Dynorphins) in mice. Behav Genet 33:529–536
Tordjman S, Gutknecht L, Carlier M, Spitz E, Antoine C, Slama F, Carsalade V, Cohen DJ, Ferrari P, Roubertoux PL, Anderson GM (2001a) Role of the serotonin transporter gene in the behavioral expression of autism. Mol Psychiatry 6:434–439
Tordjman S, Mouchabac S, Botbol M (2001b) L’enfance des adolescents schizophrènes. Nervure 14:40–46
Torres AR (2003) Is fever suppression involved in the etiology of autism and neurodevelopmental disorders? BMC Pediatr 3:9
Turner CA, Presti MF, Newman HA, Bugenhagen P, Crnic L, Lewis MH (2001) Spontaneous stereotypy in an animal model of Down syndrome: Ts65Dn mice. Behav Genet 31(4):393–400
Van Den Bosch RJ, Van Asma MJ, Rombouts R, Louwerens JW (1992) Coping style and cognitive dysfunction in schizophrenic patients. Br J Psychiatry Suppl 18:123–128
Van Engeland H, Van Der Gaag RJ (1994) MCDD in childhood: a precursor of schizophrenic spectrum disorders. Schizophr Res 11:197
Van Gent T, Heijnen CJ, Treffers PDA (1997) Autism and the immune system. J. Child Psychol Psychiat 38:337–349
Van Wimersma A, Greidanus TJB, Van de Brug F, De Bruijckere LM, Pabst PHMA, Ruesink RW, Hulshof RLE, Van Berckel BNM, Arissen SM, De Koning EJP, Donker DK (1988) Comparison of bombesin, ACTH and beta-endorphin induced grooming: antagonism by haloperidol, naloxone and neurotensin. Ann NY Acad Sci 525:219–227
Volkmar FR, Cohen DJ (1991) Comorbid association of autism and schizophrenia. Am J Psychiatry 148(12):1705–1707
Wassink TH, Piven J, Vieland VJ, Huang J, Swiderski E, Pietila J, Braun T, Beck G, Folstein SE, Haines JL, Sheffield VC (2001) Evidence supporting WNT2 as an autism susceptibility gene. Am J Med Genet 105:406–413
Watson S, Akil H, Berger P, et al (1979) Some observations on the opiate peptides and schizophrenia. Arch Gen Psychiatry 36:35–41
Weinberger DR (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660–669
Weiner I (2003) The “two-headed” latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. Psychopharmacology 169:257–297
Weiner I, Lubow RE, Feldon J (1984). Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats. Psychopharmacology 83:194–199
Weiss J, Kilts CD (1994) Animal models of depression and schizophrenia. In: Schatzberg A, Nemeroff C (eds) Textbook of psychopharmacology. American Psychiatric Press, Washington, pp 81–123
Wiedl KH (1992) Assessment of coping with schizophrenia. Stressors, appraisals, and coping behaviour. Br J Psychiatry Suppl 18:114–122
Wilkinson LS, Killcross SS, Humby T, Hall FS, Geyer MA, Robbins TW (1994) Social isolation in the rat produces developmentally specific deficits in prepulse inhibition of the acoustic startle response without disrupting latent inhibition. Neuropsychopharmacology 10(1):61–72
Willemsen-Swinkels SHN, Buitelaar JK, Nijhof GF, Van Engeland H (1995) Failure of Naltrexone to reduce self-injurious and autistic behavior in mentally retarded adults: double-blind placebo controlled studies. Arch Gen Psychiatry 52:766–773
World Health Organization (1993) The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. World Health Organization, Geneve
Wu CL, Melton DW (1993) Production of a model for Lesch–Nyhan syndrome in hypoxanthine phophoribosyltransferase-deficient mice. Nat Genet 3:235–240
Yan WL, Guan XY, Green ED, Nicolson R, Yap TK, Zhang J, Jacobsen LK, Krasnewich DM, Kumra S, Lenane MC, Gochman P, Damschroder-Williams PJ, Esterling LE, Long RT, Martin BM, Sitransky E, Rapoport JL, Ginns EI (2000) Childhood-onset schizophrenia/autistic disorder and t (1;7) reciprocal translocation: identification of a BAC contig spanning the translocation breakpoint al 7q21. Am J Med Genet 96(6):749–753
Young LJ, Winslow JT, Wang Z, Gingrich B, Guo Q, Matzuk MM, Insel TR (1997) Gene targeting approaches to neuroendocrinology: oxytocin, maternal behavior, and affiliation. Horm Behav 31:221–231
Zarifian E (1989) La Clinique et les modèles neurochimiques. Confrontations Psy: Les modèles expérimentaux et la clinique psychiatrique 30:107–111
Author information
Authors and Affiliations
Corresponding author
Additional information
Edited by Gene Fisch
Rights and permissions
About this article
Cite this article
Tordjman, S., Drapier, D., Bonnot, O. et al. Animal Models Relevant to Schizophrenia and Autism: Validity and Limitations. Behav Genet 37, 61–78 (2007). https://doi.org/10.1007/s10519-006-9120-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10519-006-9120-5